Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

Share Price Information for Argentex Group. (AGFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.90
Bid: 33.60
Ask: 34.50
Change: -0.50 (-1.45%)
Spread: 0.90 (2.679%)
Open: 34.00
High: 34.00
Low: 33.00
Prev. Close: 34.40
AGFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Long Term Incentive Plan

8 Nov 2022 12:55

RNS Number : 7122F
Argentex Group PLC
08 November 2022
 

8 November 2022

 

Argentex Group PLC

("Argentex" or the "Group")

 

New Long Term Incentive Plan

 

Argentex Group PLC, the international provider of foreign exchange services to institutions, corporates and high net worth private individuals, today announces the establishment of a new Long Term Incentive Plan ("LTIP" or the "Plan") for its executive directors and senior management team in order to incentivise and encourage retention of senior employees in a manner that aligns with the interests of the Group's shareholders. The Company has consulted with certain of its larger institutional shareholders on the LTIP.

 

New Long Term Incentive Plan

 

The LTIP is a value creation plan based on delivering value above the current Argentex equity value over the next four financial years. The Plan provides the potential for participants to earn meaningful value on the basis of strong company and share price performance with the hurdles being:

 

- compound annual total shareholder return of 10% including dividends paid or declared; and

- 15% revenue CAGR over the performance periods.

 

Subject to these hurdles being met, plan participants will earn up to 10% of value created above the shareholder return hurdle. The Plan will be performance tested and awards vest based on the average share price over 20 trading days following the publication of full year December 2025 and December 2026 results based on the following split:

 

- 50% of awards tested, vest around April 2026; and

- 50% of awards tested, vest around April 2027.

 

30% of the awards will be granted to Argentex's three most senior executives which is split 12% to each of the CEO and COO and 6% to the CFO. Initial allocations to a further 39 employees across different seniority levels are being made as one off awards with a small number of new joiners to be awarded an allocation in the first few months after the LTIP's implementation.

 

Recipients of awards under the new LTIP will include certain of the Company's Persons Discharging Managerial Responsibility ("PDMRs") as follows:

 

PDMR

Role

% of total award

No. of existing options to be cancelled

Harry Adams

CEO

12%

-

David Christie

Chief Operating Officer

12%

905,660

Jo Stent

Chief Financial Officer

6%

452,830

 

Awards made to the CEO, COO and CFO will be subject to a holding period of five years after the date awards are made.

 

The Plan will be adopted on 9 November 2022 with awards made shortly thereafter. As part of these arrangements, the Group will cancel participants' outstanding options in relation to the 2020 company share option plan (the "2020 CSOP") granted over, in aggregate, approximately 4.2 million ordinary shares. None of these options have vested to date. Under the 2020 CSOP, Argentex's CFO currently holds options over 452,830 Argentex shares and the COO holds options over 905,660 Argentex shares, both of which will be cancelled when the awards are made under the new Plan.

 

The new LTIP will be implemented by way of an issue of growth shares in a wholly owned subsidiary of Argentex whereby these growth shares will be acquired by participants at the outset at market value. Following vesting, the growth shares will be acquired by Argentex in exchange for ordinary shares in Argentex or, at Argentex's option, cash. 

 

Dilution, caps, discretion and previous long term incentives

 

The Group continues to operate within typical UK 10% over 10 years dilution limits and will apply caps to the new LTIP at a total value of £35m and total dilution arising at 6.5% of current issued ordinary shares, with the Remuneration Committee retaining the ability to waive these caps in exceptional circumstances.

 

In line with UK governance best practice, the Plan rules contain a Remuneration Committee discretion to override formulaic outcomes to ensure Plan outcomes reflect overall corporate performance, the experience of shareholders in terms of value creation and exceptional negative events. The Plan contains malus and clawback provisions.

 

Commenting on the above arrangements, Lord Digby Jones, Non-Executive Chairman, said:

 

"The board has recognised the need to review our LTIP arrangements and put in place a plan that effectively motivates and incentivises the senior team appropriately. After consultation with certain of our larger institutional shareholders, we believe now is the right time to be implementing a new plan, following the announcement of our new strategy earlier this year and at such an exciting point in our journey, and I am delighted we have been able to confirm this new LTIP scheme for the team."

 

For further information, please contact:

 

Argentex Group PLC

Harry Adams - Chief Executive Officer

Jo Stent - Chief Financial Officer

investorrelations@argentex.com

 

FTI Consulting (Financial PR)

Ed Berry / Ambrose Fullalove / Jenny Boyd

argentex@fticonsulting.com

 

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / Justin McKeegan

020 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDBDBBUGDGDI
Date   Source Headline
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update
26th Feb 20212:58 pmRNSDirector/PDMR Shareholding
17th Feb 20213:12 pmRNSHolding(s) in Company
9th Feb 20212:34 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSTrading update and Board changes
20th Nov 20207:00 amRNSInterim Results
19th Nov 20204:53 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSNotice of interim results
12th Oct 20207:00 amRNSDirector Declaration
12th Oct 20207:00 amRNSTrading Statement
6th Oct 20204:40 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20204:40 pmRNSSecond Price Monitoring Extn
30th Sep 20204:35 pmRNSPrice Monitoring Extension
21st Sep 20205:50 pmRNSChange of Registered Office
11th Sep 20202:18 pmRNSAGM Statement
7th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20207:17 amRNSAnnual Report and Notice of Annual General Meeting
3rd Aug 20207:00 amRNSFull year results for period ending 31 March 2020
29th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Full Year Results
8th Jul 20205:24 pmRNSHolding(s) in Company
29th Jun 20209:11 amRNSHolding(s) in Company
27th May 20207:00 amRNSArgentex Group announces new headquarters
26th May 20204:40 pmRNSSecond Price Monitoring Extn
26th May 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:40 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading Update
27th Mar 20204:41 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
25th Mar 20204:00 pmRNSDirector/PDMR Shareholding
18th Mar 202011:46 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.